Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone for Severe Community-Acquired Pneumonia (SOPN)
NCT04007328Phase 3Unknown
- Sponsor
- Taipei Medical University WanFang Hospital
- Start
- Jun 2019
- Primary completion
- Apr 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methylprednisolone in community acquired pneumonia (CAP), sponsored by Taipei Medical University WanFang Hospital. Status: unknown.
02
Drugs
methylprednisolone
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT04007328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04007328.